Clear Harbor Asset Management’s BioNTech BNTX Stock Holding History

Clear Harbor Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,801	Closed	-$375K	–	455
2025 Q3	$375K	Buy	3,801 +1,439	+61%	+$154K	0.03%	329
2025 Q2	$251K	Buy	+2,362	New	+$239K	0.02%	359
2025 Q1	–	Sell	-1,769	Closed	-$202K	–	416
2024 Q4	$202K	Hold	1,769	–	–	0.02%	352
2024 Q3	$210K	Buy	+1,769	New	+$163K	0.02%	331

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Clear Harbor Asset Management's BNTX Position: Q4 2025 in Review

Clear Harbor Asset Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 3,801 shares — an estimated $375K sold.

Clear Harbor Asset Management first reported a position in BNTX in Q3 2024 and held it in 4 quarters. The position peaked at $375K in Q3 2025. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

Clear Harbor Asset Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
Clear Harbor Asset Management sold 3,801 BioNTech shares in Q4 2025, an estimated $375K.
Clear Harbor Asset Management first reported a position in BioNTech in Q3 2024 and held it in 4 quarters.
Clear Harbor Asset Management's BioNTech position peaked at $375K in Q3 2025.
284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Clear Harbor Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.